ONCORE

Serial Number 85706751
Registration 4442331
800

Registration Progress

Application Filed
Aug 17, 2012
Under Examination
Approved for Publication
Sep 17, 2013
Published for Opposition
Sep 17, 2013
Registered
Dec 3, 2013

Trademark Image

ONCORE

Basic Information

Serial Number
85706751
Registration Number
4442331
Filing Date
August 17, 2012
Registration Date
December 3, 2013
Published for Opposition
September 17, 2013
Renewal Date
December 3, 2023
Drawing Code
5

Status Summary

Current Status
Active
Status Code
800
Status Date
May 27, 2024
Registration
Registered
Classes
042

Rights Holder

ADVARRA, INC.

03
Address
6100 Merriweather Drive, Suite 600
Columbia, MD 21044

Ownership History

Forte Research Systems, Inc.

Original Applicant
03
Madison, WI

Forte Research Systems, Inc.

Owner at Publication
03
Madison, WI

Forte Research Systems, Inc.

Original Registrant
03
Madison, WI

ADVARRA RESEARCH TECHNOLOGIES, INC.

New Owner After Registration #1
03
MADISON, WI

ADVARRA TECHNOLOGY SOLUTIONS, INC.

New Owner After Registration #2
03
MADISON, WI

ADVARRA, INC.

New Owner After Registration #3
03
Columbia, MD

Legal Representation

Attorney
Andrew J. Ferren

USPTO Deadlines

Next Deadline
2855 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20131203)
Due Date
December 03, 2033
Grace Period Ends
June 03, 2034

Application History

46 events
Date Code Type Description Documents
May 27, 2024 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED Loading...
May 27, 2024 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) Loading...
May 27, 2024 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED Loading...
May 27, 2024 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Feb 14, 2024 E89R I TEAS SECTION 8 & 9 RECEIVED Loading...
Jan 25, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Dec 3, 2022 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED Loading...
Nov 2, 2022 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Sep 24, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 24, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 24, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Sep 24, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Sep 24, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Sep 22, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 15, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 8, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Dec 6, 2019 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Dec 6, 2019 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Nov 30, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Oct 25, 2019 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Sep 18, 2019 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Dec 3, 2018 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Apr 29, 2015 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Dec 3, 2013 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 17, 2013 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 17, 2013 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 28, 2013 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 15, 2013 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Aug 14, 2013 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 14, 2013 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 14, 2013 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 14, 2013 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 14, 2013 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 14, 2013 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Aug 7, 2013 ALIE A ASSIGNED TO LIE Loading...
Jul 25, 2013 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 15, 2013 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 15, 2013 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 15, 2013 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 15, 2012 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 15, 2012 GNRT F NON-FINAL ACTION E-MAILED Loading...
Dec 15, 2012 CNRT R NON-FINAL ACTION WRITTEN Loading...
Dec 12, 2012 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 28, 2012 MPMK O NOTICE OF PSEUDO MARK MAILED Loading...
Aug 27, 2012 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 21, 2012 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing on-line non-downloadable software for use in design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; [ providing a website featuring non-downloadable software for use in the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; ] Hosting, managing, developing, and maintaining [ web sites, ] software, and applications for use by pharmaceutical companies and others in the design and administration of scientific and medical research projects, and of clinical trials for pharmaceuticals, medical devices and medical procedures; Providing on-line non-downloadable software for use in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures, providing a website featuring non-downloadable software for use in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and [ regarding clinical trials for pharmaceuticals, medical devices and medical procedures; Hosting, managing, developing, and maintaining [ web sites, ] software, applications, and databases for use by pharmaceutical companies and others in data collection, data sharing, information exchange, and collaboration regarding scientific and medical research projects, and regarding clinical trials for pharmaceuticals, medical devices and medical procedures; Providing on-line non-downloadable software for use by pharmaceutical companies and others in the tracking and management of patients, specimens, equipment, materials, funding, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures, providing a website featuring non-downloadable software for use by pharmaceutical companies and others in the tracking and management of patients, specimens, equipment, materials, funding, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; Hosting, managing, developing, and maintaining [ web sites, ] software, and applications for use by pharmaceutical companies and others in the tracking and management of patients, specimens, equipment, materials, funding, schedules, and performance milestones and metrics involved in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; Providing on-line non-downloadable software for use by pharmaceutical companies and others in the monitoring and reporting of regulatory, standards, and safety compliance in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures, providing a website featuring non-downloadable software for use by pharmaceutical companies and others in the monitoring and reporting of regulatory, standards, and safety compliance in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; Hosting, managing, developing, and maintaining [ web sites, ] software, and applications for use by pharmaceutical companies and others in the monitoring and reporting of regulatory, standards, and safety compliance in scientific and medical research, and in clinical trials for pharmaceuticals, medical devices and medical procedures; consulting services regarding all of the foregoing
First Use Anywhere: Aug 16, 2012
First Use in Commerce: Aug 16, 2012

Additional Information

Design Mark
The mark consists of the word "ONCORE" in stylized text.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ON CORE

Classification

International Classes
042